San Diego’s Biological Dynamics is set to receive a $1 million grant from the Bill & Melinda Gates Foundation to push forward its tuberculosis test that’s designed for areas without access to advanced medical equipment.
Sanford Burnham Prebys Medical Discovery Institute has made two additions to its board who are well known in San Diego’s education and health care circles: Karen Haynes and Donald Kearns.
“The VR perspective and intuitive manipulation allows you to get a really good feel for the structure..."
Acuity Eye Group has purchased La Jolla Laser Vision & Eye Center for an undisclosed amount.
Vividion Therapeutics – a San Diego upstart that last year raised an $82 million financing round – has announced the hiring of a former Pfizer executive.
MEDICINE: Investor Interest Swirls around Companies
A crop of life sciences companies are rushing to combat the coronavirus outbreak, triggering big movements in their stocks and millions in grant funding.
Illumina recently made a major addition to its board: Scott Gottlieb, the former commissioner of the U.S. Food and Drug Administration.
The Bill & Melinda Gates Foundation has awarded $50 million to a division of Scripps Research to push forward potential therapies for tuberculosis and malaria.
The Association for Creatine Deficiencies was awarded a $450,000 grant to combat a trio of disorders that can cause intellectual delays.
San Diego company MeBe on Feb. 15 is slated to open a center catering to young adults and children with autism and special needs.
Conatus Pharmaceuticals has agreed to merge with another San Diego biotech, Histogen, it was announced Jan. 28.
Inovio Pharmaceuticals was recently awarded up to a $9 million grant to develop a vaccine against a strain of coronavirus that’s spreading in China and spurred screening at U.S. airports.
Illumina reported revenue of $953 million in fourth quarter revenue, a 10% year-over-year increase that also beat analyst expectations.
ResMed will pay $37.5 million to settle allegations that the company paid kickbacks to suppliers, sleep labs and other health care providers, the Department of Justice recently announced.
Tyra Biosciences, a Carlsbad company that wants to combat cancers that become drug-resistant, has raised a $50 million round.